Multiple myeloma is the second most common type...

By HEOR Staff Writer

March 29, 2023

A health technology assessment (HTA) of treatment regimens for patients with multiple myeloma in Norway was done. The goals of treatment are to prolong life, achieve a strong response without side effects, and maintain quality of life. The arti...
HTA must consider health equity for progress
Comprehensive Review of Methods to Assess Uncertainty in Health Economic Eval...
Increases in drug prices are of concern to worldwide health systems
HEOR Theater focusing on discussions from the ISPOR HTA Roundtable
HIQA’s Report on Repatriating Paediatric Stem Cell Transplants
Abu Dhabi (DoH), Hosted “DoH Innovation Week 2023″
Reimbursement Processes for Keytruda in Israel, UK, and Australia
HIQA on Gene Expression Profiling Tests for Breast Cancer
Using Health Policy and Systems Research to Influence National Health Policies
Opportunity to undertake an MSc in Health Economics at the University of London
Biosimilar uptake in public hospitals: NHS Hospitals
Amputations under PMB Regulations: The Latest CMScript